Finance

Lists
XBIT:NASDAQ
XBiotech Inc
$2.19
-0.23%
(-0.0050) 1D
Sep 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XBIT...
Open
$2.17
High
$2.20
Low
$2.16
Mkt. cap
66.92M
Avg. vol.
43.06K
Volume
0.00
52-wk high
$3.44
52-wk low
$2.09
EPS
-$1.48
Beta
0.85
Shares outstanding
30.49M
No. of employees
87
Open
$2.17
High
$2.20
Low
$2.16
Mkt. cap
66.92M
Avg. vol.
43.06K
Volume
0.00
52-wk high
$3.44
52-wk low
$2.09
EPS
-$1.48
Beta
0.85
Shares outstanding
30.49M
No. of employees
87
Profile
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
About XBiotech Inc
CEO-
Employees87
Founded2005
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitexbiotech.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.08M
25.36M
5.21M
5.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
967.00K
4.40M
1.07M
850.00K
Operating expense
6.05M
29.76M
6.27M
6.15M
Total operating expenses
6.05M
29.76M
6.27M
6.15M
Operating income
-6.05M
-29.76M
-6.27M
-6.15M
Other non operating income
-85.00K
-8.00K
1.04M
-9.00K
EBT including unusual items
-5.91M
-26.82M
-5.46M
-6.68M
EBT excluding unusual items
-5.91M
-27.37M
-5.46M
-6.68M
Income tax expense
102.00K
76.00K
49.00K
46.00K
Effective tax rate
-1.73%
-0.28%
-0.90%
-0.69%
Other operating expenses
-
-
-
-
Net income
-6.01M
-26.89M
-5.50M
-6.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.43M
1.22M
914.00K
885.00K
Interest expense
-
-
-
-
Net interest expenses
1.43M
1.22M
914.00K
885.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.62M
-29.38M
-5.94M
-5.84M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps